A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
about
A method for optimizing dosage regimens in oncology by visualizing the safety and efficacy response surface: analysis of inotuzumab ozogamicin.Emerging antibody-drug conjugates for treating lymphoid malignancies.New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma.Targeting indolent non-Hodgkin lymphoma.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications.Antibody-Drug Conjugates for Cancer Therapy.
P2860
Q33434352-40BE6631-0999-4F6C-BA75-D46994AE4D8CQ38632313-25BC7F9E-836E-4AA4-AC0D-71A9E773F855Q38896683-414654B8-0162-4FFC-9645-F163D4E62875Q38917848-7890F0BC-2145-4396-AE7F-D1CA510B92B7Q47221234-A8401A48-32E9-43FB-AA66-1C82DF4DB940Q47563526-3047AFCE-59AC-456E-97F6-1FEDF932B9B4Q52593621-89D806BE-C198-453E-AECA-7C514408713FQ53739135-A7D5911B-A351-4A15-8B60-E5D66BFCD03B
P2860
A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@ast
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@en
type
label
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@ast
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@en
prefLabel
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@ast
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@en
P2093
P2860
P356
P1476
A phase 2 study of inotuzumab ...... herapy, or radioimmunotherapy.
@en
P2093
Andres Forero
Angela Volkert
Erik Vandendries
Kiyohiko Hatake
Michaela Tsai
Michinori Ogura
Nina Wagner-Johnston
Revathi Ananthakrishnan
W Christopher Ehmann
P2860
P304
P356
10.1111/BJH.14094
P407
P577
2016-04-22T00:00:00Z